No Doubts with your drug development
Cross checking your HPLC method for impurity profiling with TLC.
Petra Lewits, Product Manager for HPLC at Merck KGaA Darmstadt Germany presents her poster on how TLC & TLC-MS can support a full analytical picture in pharmaceutical drug development.
Cross checking your HPLC method for impurity profiling with Thin Layer Chromatography will allow you to overcome the limitations of HPLC. Visit the link for more information.
Click here to download MilliporeSigma’s Scientific Poster.
Video taken at HPLC, July 2018.
If you would like to be contacted by Merck, please complete the form below:
Related content from this organisation
- Full data set for new buffer stock blending system freely available
- $65 million expansion to HPAPI manufacturing facility
- QA/QC & Analytical Techniques In-Depth Focus 2020
- QA/QC & Analytical Techniques In-Depth Focus 2020 with a special focus on Chromatography & Microbiology
- Challenges in today’s pharmaceutical formulation
